Menora Mivtachim Holdings Ltd. Abb Vie Inc. Transaction History

Menora Mivtachim Holdings Ltd.

$14.5 Billion
Q2 2024

A detailed history of Menora Mivtachim Holdings Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Menora Mivtachim Holdings Ltd. holds 1,539,609 shares of ABBV stock, worth $304 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares

1,539,609

Previous 1,539,609 -0.0%

Holding current value

$304 Million

Previous $280 Million 5.81%

% of portfolio

1.82%

Previous 2.14%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $57.6 Million - $65.7 Million	360,664 Added 30.59%	1,539,609 $280 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $37.7 Million - $42.5 Million	274,000 Added 30.28%	1,178,945 $183 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $2.19 Million - $2.54 Million	-16,400 Reduced 1.78%	904,945 $135 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $397,530 - $494,700	-3,000 Reduced 0.32%	921,345 $124 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1.02 Million - $1.17 Million	-7,025 Reduced 0.75%	924,345 $147 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $25.3 Million - $31.4 Million	192,050 Added 25.98%	931,370 $151 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $319,200 - $362,340	3,000 Added 0.41%	739,320 $79.8 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $77.3 Million - $85.1 Million	-755,280 Reduced 50.64%	736,320 $79.7 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $27.6 Million - $37.2 Million	342,600 Added 29.82%	1,491,600 $160 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $46.7 Million - $54.9 Million	544,000 Added 89.92%	1,149,000 $101 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $44.4 Million - $59.4 Million	605,000 New	605,000 $59.4 Million

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.

Account

Menora Mivtachim Holdings Ltd. Abb Vie Inc. Transaction History